Next generation gene therapy
4basebio is at the forefront of biotechnology, dedicated to enabling next-generation cell and gene therapies and vaccines through its innovative technologies and solutions. The company specializes in the design, manufacture, and supply of application-specific synthetic DNA or mRNA, as well as targeted non-viral vectors for the delivery of nucleic acid payloads.
Located at 25 Norman Way, Over, Cambridge, CB245QE, GB, 4basebio’s novel synthetic DNA technology offers unique customization potential, rapid turnaround times, and improved safety profiles, effectively addressing the current limitations of plasmids and other DNA technologies. With a range of DNA construct types ideally suited for viral and non-viral vector applications, genome editing, vaccines and therapeutics, and DNA vaccine applications, 4basebio is well-equipped to meet diverse needs.
Furthermore, 4basebio's proprietary non-viral delivery system, Hermes™, represents a significant advancement. This nanoparticle vector can be customized to target specific cells or tissues, combining the safety and efficiency of lipid-based nanoparticles (LNPs) with the specificity of a targeting system. We invite the management team at 4basebio to create a customized and exclusive company showcase and product listing on our platform to further highlight its capabilities and innovations.
Other organizations in the same industry
This company is also known as